André Potti obtained funding for a project aimed at researchers with an excellent track record. The project will focus on the development of precision immunomodulatory tools based on semi-artificial extracellular vesicles (exosomes) from immune cells for promoting T lymphocyte responses. The success of this project will allow the development of multifunctional nanocarriers to induce specific responses in the context of chronic diseases.
News
A. Potti secures a new grant for research consolidation (GAIN – Xunta de Galicia 2024)
07.23.2024
Share:
BNT participating at 9th International MOF2024
M. Ceballos is presenting his recent work about nanoMOFs at the MOF 2024, 9th International Conference on Metal-Organic Frameworks and Open Framework Compounds in Singapore (15th -19th July 2024) https://mof2024.mrs.org.sg/
Platelet-derived nanocarriers for improving thrombolytic therapy
Researchers from CiQUS and the Institute of Health Research of Santiago de Compostela optimized the available pharmacological treatment for ischemic stroke using biomimetic nanoparticles. Their study, “Lyophilized platelet-derived nanocarrier-based thrombolytic
Open Doors Day- Ciencia Singular
BNT members participating at the Open Doors Day at CiQUS. CiQUS, CiMUS CiTIUS and IGAFE celebrate the largest annual outreach meeting, which invites families and visitors of all ages to
